通策医疗
(600763)
| 流通市值：184.19亿 | | | 总市值：184.19亿 |
| 流通股本：4.47亿 | | | 总股本：4.47亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 744,611,704.47 | 2,873,776,923.07 | 2,233,126,548.77 | 1,410,579,723.34 |
| 营业收入 | 744,611,704.47 | 2,873,776,923.07 | 2,233,126,548.77 | 1,410,579,723.34 |
| 二、营业总成本 | 516,786,428.41 | 2,228,564,644.29 | 1,606,451,888.31 | 1,033,135,038.13 |
| 营业成本 | 415,447,933.54 | 1,767,306,262.03 | 1,299,312,591.18 | 834,646,337.67 |
| 税金及附加 | 573,523.56 | 5,716,278.42 | 4,103,781.04 | 3,512,431.34 |
| 销售费用 | 6,984,707.73 | 31,941,472.24 | 25,708,384.75 | 13,985,464.77 |
| 管理费用 | 72,558,232.19 | 316,288,401.87 | 200,368,712.64 | 135,392,703.58 |
| 研发费用 | 11,936,367.6 | 58,952,690.28 | 41,050,496.48 | 22,956,198.63 |
| 财务费用 | 9,285,663.79 | 48,359,539.45 | 35,907,922.22 | 22,641,902.14 |
| 其中:利息费用 | 7,775,033.5 | 45,436,507.93 | 32,972,516.68 | 21,303,740.61 |
| 其中:利息收入 | 566,242.46 | 4,097,081.08 | 3,253,316.03 | 2,239,217.43 |
| 加:公允价值变动收益 | - | 1,417,168.24 | - | - |
| 加:投资收益 | 11,195,169.04 | 46,427,350.82 | 37,386,765.97 | 24,689,597.9 |
| 资产处置收益 | -15,150.28 | 141,002.18 | 62,393.75 | - |
| 资产减值损失(新) | - | 154,517.35 | - | - |
| 信用减值损失(新) | -1,459,025.43 | -1,447,345.72 | 1,487,698.86 | 1,577,981.75 |
| 其他收益 | 2,524,163.23 | 6,727,275.29 | 4,444,244.51 | 4,081,388.45 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 240,070,432.62 | 698,632,246.94 | 670,055,763.55 | 407,793,653.31 |
| 加:营业外收入 | 173,772.26 | 209,910.28 | 250,120.48 | 222,251.51 |
| 减:营业外支出 | 349,002.93 | 4,833,104.62 | 2,414,941.64 | 1,046,032.73 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 239,895,201.95 | 694,009,052.6 | 667,890,942.39 | 406,969,872.09 |
| 减:所得税费用 | 23,791,802.29 | 121,877,563.17 | 66,130,122.51 | 39,386,269.97 |
| 六、净利润 | 216,103,399.66 | 572,131,489.43 | 601,760,819.88 | 367,583,602.12 |
| 持续经营净利润 | 216,103,399.66 | 572,131,489.43 | 601,760,819.88 | 367,583,602.12 |
| 归属于母公司股东的净利润 | 183,925,013.61 | 501,426,889.23 | 498,270,940.75 | 309,811,977.84 |
| 少数股东损益 | 32,178,386.05 | 70,704,600.2 | 103,489,879.13 | 57,771,624.28 |
| (一)基本每股收益 | 0.41 | 1.12 | 1.11 | 0.97 |
| (二)稀释每股收益 | 0.41 | 1.12 | 1.11 | 0.97 |
| 八、其他综合收益 | 0.05 | -109,339,073.44 | -7,667,509.45 | -7,667,509.45 |
| 归属于母公司股东的其他综合收益 | 0.05 | -109,339,073.44 | -7,667,509.45 | -7,667,509.45 |
| 九、综合收益总额 | 216,103,399.71 | 462,792,415.99 | 594,093,310.43 | 359,916,092.67 |
| 归属于母公司股东的综合收益总额 | 183,925,013.66 | 392,087,815.79 | 490,603,431.3 | 302,144,468.39 |
| 归属于少数股东的综合收益总额 | 32,178,386.05 | 70,704,600.2 | 103,489,879.13 | 57,771,624.28 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-29 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |